Anti-Toll-like receptor 4 TLR4 Antibody Picoband® PA1484 from BosterBio

Product Specs
ItemAnti-Toll-like receptor 4 TLR4 Antibody Picoband®
CompanyBosterBio
Price $370.00Supplier Page View Company Product Page
Catalog NumberPA1484
Quantity100 µg/vial
ApplicationsIHC,WB
FormatEach vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2mg Na2HPO4, 0.05 mg NaN3., Lyophilized
PurityImmunogen affinity purified
ReactivityHuman
ImmunogenA synthetic peptide corresponding to a sequence at the N-terminus of human TLR4
ClonalityPolyclonal
Gene NameTLR4
NCBI Gene AliasesTLR-4, TOLL, CD284, ARMD10
ConcentrationAdding 0.2 ml of distilled water will yield a concentration of 500 µg/ml
HostRabbit
Molecular Weight95680 MW, Observed: 80 kDa
Calculated: 95680 MW
Research AreaAdaptive Immunity,Atherosclerosis,Cardiovascular,Host-Virus Interaction,Immunoglobulins,Immunology,Innate Immunity,Interspecies Interaction,Macrophage/Inflammation,Microbiology,Receptors,TLR Signaling,Vascular Inflammation
StorageStore at -20℃ for one year from date of receipt. After reconstitution, at 4℃ for one month. It can also be aliquotted and stored frozen at -20℃ for six months. Avoid repeated freeze-thaw cycles
IsotypeIgG
TargetToll-like receptor 4
Antibody TypePrimary Antibodies
Conjugate/TagBiotin, Cy3, Fluoro488, Fluoro550, Fluoro594, FITC, HRP, APC, PE, Fluoro647, carrier-free

3942 B Valley Ave.

Pleasanton, CA 94566

United States

Phone: (888) 466-3604
Fax: (925)215-2184

Email: support@bosterbio.com

(1) Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cellsInternational journal of immunopathology and pharmacologyJanuary 1, 2024Wang Y, Li Y, Chen Y, Mao J, Ji J, Zhang S, Liu P, Pronyuk K, Fisher D, Dang Y, et al.

(2) MiR-24 regulates obstructive pulmonary disease in rats via S100A8Experimental lung researchJanuary 1, 2024Guo S, Liu Q, Tan T, Chen X.

(3) Total glycosides of Rhodiola rosea L. attenuate LPS-induced acute lung injury by inhibiting TLR4/NF-κB pathwayBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieFebruary 1, 2023Jia X, Zhang K, Feng S, Li Y, Yao D, Liu Q, Liu D, Li X, Huang J, Wang H, et al.

(5) A study of diabetes-induced erectile dysfunction treated with human umbilical cord mesenchymal stem cellsAndrologiaAugust 1, 2022Wang S, Zhang A, Liu K, Pan Y, Kang J, Niu S, Song Y, Zhang Z, Li Y, Liu L, et al.

(6) Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammationActa pharmacologica SinicaApril 1, 2022Wang W, Li SS, Xu XF, Yang C, Niu XG, Yin SX, Pan XY, Xu W, Hu GD, Wang C, et al.

(14) Autophagy inhibits TLR4-mediated invasiveness of oral cancer cells via the NF-κB pathwayOral diseasesSeptember 1, 2020Kong Q, Liang Y, He Q, You Y, Wu L, Liang L, Liang J.

(15) HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathwayEuropean journal of pharmacologyAugust 5, 2020Wang F, Ji S, Wang M, Liu L, Li Q, Jiang F, Cen J, Ji B.

(16) Tetramethylpyrazine attenuates endotoxin-induced retinal inflammation by inhibiting microglial activation via the TLR4/NF-κB signalling pathwayBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapieAugust 1, 2020Han X, Chen X, Chen S, Luo Q, Liu X, He A, He S, Qiu J, Chen P, Wu Y, et al.

(19) Physicochemical characterization of polysaccharide from the leaf of Dendrobium officinale and effect on LPS induced damage in GES-1 cellInternational journal of biological macromoleculesApril 15, 2020Yang K, Lu T, Zhan L, Zhou C, Zhang N, Lei S, Wang Y, Yang J, Yan M, Lv G, et al.

Anti-Toll-like receptor 4 TLR4 Antibody